Begin main content

Reports

We found 5223 result(s)

Nusinersen (Spinraza)

Last Updated: October 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Nusinersen
Indications: Spinal Muscular Atrophy

  • Brand Name: Spinraza
  • Manufacturer: Biogen Canada Inc.
  • Project Number: SR0576-000
  • Project Status: Active
  • Submission Type: Resubmission

Tags

Genetics, Nervous System, Pediatrics, Genetics, Musculoskeletal, Nervous system, Pediatrics

ertugliflozin and metformin (Segluromet)

Last Updated: October 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: ertugliflozin and metformin hydrochloride
Indications: Diabetes mellitus, Type 2

  • Brand Name: Segluromet
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0566-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Diabetes Mellitus, Diabetes, segluromet; ertugliflozin; metformin; Diabetes; Diabetic

ertugliflozin (Steglatro)

Last Updated: October 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: ertugliflozin
Indications: Diabetes mellitus, Type 2

  • Brand Name: Steglatro
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0565-000
  • Project Status: Active
  • Submission Type: New

Tags

Diabetes Mellitus, Diabetes, steglatro; ertugliflozin; Diabetes; Diabetic

insulin glargine (Semglee)

Last Updated: October 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: insulin glargine
Indications: Diabetes mellitus, Type 1 & 2

  • Brand Name: Semglee
  • Manufacturer: BGP PHARMA ULC
  • Project Number: SE0589-000
  • Project Status: Pending
  • Submission Type: New

pegfilgrastim (Fulphila )

Last Updated: October 16, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: pegfilgrastim
Indications: Febrile neutropenia in non-myeloid malignancies

  • Brand Name: Fulphila
  • Manufacturer: BGP PHARMA ULC
  • Project Number: SE0588-000
  • Project Status: Pending
  • Submission Type: New

telotristat (TBC)

Last Updated: October 15, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Telotristat
Indications: carcinoid syndrome

  • Brand Name: TBC
  • Manufacturer: Ipsen Biopharmaceuticals Canada Inc.
  • Project Number: SR0580-000
  • Project Status: Active
  • Submission Type: New

Tags

Cancer, Cancer

lumacaftor/ivacaftor (Orkambi )

Last Updated: October 12, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: lumacaftor/ivacaftor
Indications: Cystic Fibrosis, F508del CFTR mutation in patients 6 years and older

  • Brand Name: Orkambi
  • Manufacturer: Vertex Pharmaceuticals (Canada) Incorporated
  • Project Number: SR0559-000
  • Project Status: Complete
  • Submission Type: NewIndication

Tags

Cystic Fibrosis, Cystic Fibrosis, Cystic Fibrosis, Respiratory, Cystic Fibrosis, ivacaftor; lumacaftor; orkambi; mucoviscidosis